Tag Archives: 586

PTO Issues Section 101 Memorandum after Vanda Decision

I have posted twice recently on the Fed. Cir.’s opinion in Vanda Pharms., Inc. v. West-Ward Pharm. Int’l, Ltd., Appeal no. 2016-2107 (Fed. Cir., April 18, 2018). The Fed. Cir. affirmed the district court’s ruling that Vanda’s claims in U.S. … Continue reading

Posted in Federal Circuit, Opinion Practice, Section 101, USPTO Practice and Policy | Tagged , , , , , , , , | Leave a comment